U.S. Markets open in 13 hrs, 50 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,430.21 | 12.78 | 0.11% |
| NASDAQ | 2,380.38 | -8.70 | -0.36% |
| S&P 500 | 1,277.72 | 3.18 | 0.25% |
| Day Low 12:16 PM EDT | 2.55 | |
|---|---|---|
| Day High 09:31 AM EDT | 2.84 |
|
| Range | 0.29 | |
| Volume | 51,630 | |
| 30-Day Avg. Vol. | 134,000 |
|
| Difference | -61.47% | |
| Market Cap. | 76.44 M | |
| Change | -2.37 M | |
| Shares Out. | 29.68 M | |
| Percent Traded | 0.17% | |
| Revenue | 21.4 M | |
| Earnings | -47.86 M | |
| EPS (TTM) | -2.08 |
| 52-Wk Low 12:16 PM EDT | 2.55 | |
|---|---|---|
| 52-Wk High 9/27/07 | 6.10 |
|
| Range | 3.55 | |
| Prev. Close 8/20/08 | 2.65 | |
| Today's Open | 2.63 | |
| Change | -0.75% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.2431 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -1.00 |
Pharmacopeia has searched its libraries and found some promising compounds. The biotech drug discovery firm has moved from sifting through and identifying small molecule compounds, to actually taking a ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.365 3/31/08 | -0.40 3/31/08 |
-0.035
Missed
|
| Last Quarter | -0.43 6/30/08 | -0.53 6/30/08 |
-0.10
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 5.88 M | 21.41 M |
| Gross Profit | -1.33 M | -2.33 M |
| Operating Income | -13.60 M | -52.59 M |
| Net Income | -15.60 M | -47.86 M |
Real-Time Quote
